메뉴 건너뛰기




Volumn 5, Issue 9, 2010, Pages 813-818

How to conduct research in the pharmaceutical industry? Facing the dilemma: Small, autonomous teams versus large, integrated centers

Author keywords

Attrition; Challenging future; Cost cutting; Drug research; Innovation; New molecular entities; Organizational structure; Performance; Pharmaceutical R D; Productivity; Project portfolio; Risk

Indexed keywords

ATORVASTATIN; ENOXAPARIN; ESCITALOPRAM; VENLAFAXINE;

EID: 77955962957     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.2010.504204     Document Type: Review
Times cited : (3)

References (16)
  • 1
    • 73449139146 scopus 로고    scopus 로고
    • Pharmaceutical industry financial performance
    • Goodman M. Pharmaceutical industry financial performance. Nat Rev Drug Discov 2009;8:927-928
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 927-928
    • Goodman, M.1
  • 2
    • 43949101389 scopus 로고    scopus 로고
    • Rebuilding the R&D engine in big pharma
    • Garnier JP. Rebuilding the R&D engine in big pharma. Harvard Bus Rev 2008;86:68-76
    • (2008) Harvard Bus Rev , vol.86 , pp. 68-76
    • Garnier, J.P.1
  • 3
    • 75949085017 scopus 로고    scopus 로고
    • FDA drug approvals
    • Hughes B. 2009 FDA drug approvals. Nat Rev Drug Discov 2010;9:89-92
    • (2009) Nat Rev Drug Discov , vol.2010 , Issue.9 , pp. 89-92
    • Hughes, B.1
  • 6
    • 77955930690 scopus 로고    scopus 로고
    • CMR International (2009 FactBook) & IMS Health
    • CMR International (2009 FactBook) & IMS Health
  • 7
    • 77749335431 scopus 로고    scopus 로고
    • Transforming pharma
    • Jarvis LM. Transforming Pharma. Chem Eng News 2010;88:24-26
    • (2010) Chem Eng News , vol.88 , pp. 24-26
    • Jarvis, L.M.1
  • 9
    • 77649234756 scopus 로고    scopus 로고
    • How to improve R&D productivity: The pharmaceutical industrys grand challenge
    • Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: the pharmaceutical industrys grand challenge. Nat Rev Drug Discov 2010;9:203-214
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 203-214
    • Paul, S.M.1    Mytelka, D.S.2    Dunwiddie, C.T.3
  • 10
    • 77955964367 scopus 로고    scopus 로고
    • Evaluate pharma alpha world preview 2014
    • Evaluate Pharma Alpha World Preview 2014. Evaluate Pharma report 2009
    • (2009) Evaluate Pharma Report
  • 11
    • 73449101512 scopus 로고    scopus 로고
    • Lessons from 60 years of pharmaceutical innovation
    • Munos B. Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov 2009;8:959-968
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 959-968
    • Munos, B.1
  • 12
    • 70350061512 scopus 로고    scopus 로고
    • An unbalanced portfolio
    • Federsel HJ. An unbalanced portfolio. Drug News Perspect 2009;22:287-292
    • (2009) Drug News Perspect , vol.22 , pp. 287-292
    • Federsel, H.J.1
  • 13
    • 38349090575 scopus 로고    scopus 로고
    • The state of innovation in drug development
    • Kola I. The state of innovation in drug development. Clin Pharmacol Ther 2008;83:227-230
    • (2008) Clin Pharmacol Ther , vol.83 , pp. 227-230
    • Kola, I.1
  • 14
    • 77950624325 scopus 로고    scopus 로고
    • Overcoming the obstacles in the pharma/biotech industry: 2009 update
    • Graul AI, Revel L, Tell M, et al. Overcoming the obstacles in the pharma/biotech industry: 2009 update. Drug News Perspect 2010;23:48-63
    • (2010) Drug News Perspect , vol.23 , pp. 48-63
    • Graul, A.I.1    Revel, L.2    Tell, M.3
  • 16
    • 77749293091 scopus 로고    scopus 로고
    • Timely transformation
    • Ainsworth S. Timely transformation. Chem Eng News 2009;87:13-21
    • (2009) Chem Eng News , vol.87 , pp. 13-21
    • Ainsworth, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.